Bioventus Focused on Double-Digit Growth and Debt Reduction
The company's orthopedic sales grew 9% organically in 1Q22 as Bioventus targets double-digit organic growth for the full year. May 17, 2022
Treace Benefits from Commercial Investments
The company grew more than 55% in 1Q22 on the strength of its narrow procedure focus and expanding direct sales force. May 17, 2022
Vericel Reaffirms MACI Guidance for 2022
The company grew in the high single-digits during a better than expected 1Q22 and restated its full-year guidance for MACI. May 16, 2022
Conformis Continues Business Model Transition
The company grew in the low-teens for 1Q22 as procedures rebounded, but its ongoing business model transition incurred higher costs. May 16, 2022
Globus Medical Continues Evolution Toward Full-Service Musculoskeletal Player
The company will embark on the next phase of its evolution under the guidance of new CEO Dan Scavilla, who has been with Globus since 2015. May 15, 2022
Paragon 28 Takes Share in Fast-Growing Segments
The company grew 25% in the first quarter of 2022 on the strength of its expanding portfolio, salesforce and surgeon base. May 13, 2022
Anika Gets Bounce from Order Timing in OA Pain Business
The company grew in the low double digits for the first quarter of 2022 based on favorable order timing in its viscosupplement business. May 13, 2022
Globus Starts Slow But Reaffirms Guidance for 2022
The company grew in the low single digits for 1Q22 due to a tough comparison and a stagnant robotic sales pipeline. May 12, 2022
Enovis Sets Sights on $2 Billion in 2024
The company grew over 60% in 1Q21 as recent acquisitions added momentum to Enovis' already impressive share gains. May 12, 2022
SeaSpine Attracting New Surgeons and Distributors in 2022
The company grew over 20% in the first quarter of 2022 as it wins over new surgeons and more exclusive distribution. May 11, 2022
